Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: Analysis from the TAXUS-IV trial

Journal of the American College of Cardiology

Volumn 45, Issue 8, 2005, Pages 1165-1171

  Moses, Jeffrey W ^a,b   Mehran, Roxana ^a,b   Nikolsky, Eugenia ^a,b   Lasala, John M ^c   Corey, Woodrow ^d   Albin, Glenn ^e   Hirsch, Cary ^f   Leon, Martin B ^a,b   Russell, Mary E ^g   Ellis, Stephen G ^h   Stone, Gregg W ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Teaching Faculty   (United States)

^e ST MARY S HOSPITAL   (United States)

^f VALLEY HOSPITAL   (United States)

^g BOSTON SCIENTIFIC CORPORATION   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; POLYMER;

ACUTE DISEASE; ADULT; ARTICLE; BIOSAFETY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SLOW DRUG RELEASE; UNSTABLE ANGINA PECTORIS;

EID: 20244361958     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.10.074     Document Type: Article

References (21)

1. E. Braunwald, E.M. Antman, J.W. Beasley American College of Cardiology American Heart Association Committee on the Management of Patients with Unstable Angina ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
2. A.M. Lincoff, R.M. Califf, D.J. Moliterno Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators N Engl J Med 341 1999 319 327
3. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators FRISC II prospective randomised multicentre study. Invasive compared with non-invasive treatment in unstable coronary-artery disease Lancet 354 1999 708 715
4. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis In Myocardial Infarction 18 Investigators Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
5. E. Boersma, K.M. Akkerhuis, P. Theroux, R.M. Califf, E.J. Topol, M.L. Simoons Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes early benefit during medical treatment only, with additional protection during percutaneous coronary intervention Circulation 100 1999 2045 2048
6. A. Odell, T. Gudnason, T. Andersson, H. Jidbratt, L. Grip One-year outcome after percutaneous coronary intervention for stable and unstable angina pectoris with or without application of general usage of stents in unselected European patient groups Am J Cardiol 90 2002 112 118
7. P. de Groote, C. Bauters, E.P. McFadden, J.M. Lablanche, F. Leroy, M.E. Bertrand Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty Circulation 91 1995 968 972
8. M.C. Morice, P.W. Serruys, J.E. Sousa RAVEL Study Group Randomized study with the sirolimus-coated bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
9. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
10. J. Schofer, M. Schluter, A.H. Gershlick E-SIRIUS Investigators Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
11. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
12. R. Virmani, A.P. Burke, A. Farb, F.D. Kolodgie Pathology of the unstable plaque Prog Cardiovasc Dis 44 2002 349 356
13. C.W. Hamm, E. Braunwald A classification of unstable angina revisited Circulation 102 2000 118 122
14. P.B. Clarkson, M. Halim, K.K. Ray Coronary artery stenting in unstable angina pectoris a comparison with stable angina pectoris Heart 81 1999 393 397
15. G.W. Stone, S.G. Ellis, D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent the TAXUS-IV trial Circulation 109 2004 1942 1947
16. G.W. Stone, D.J. Moliterno, M. Bertrand Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting the TARGET trial Circulation 105 2002 2347 2354
17. D.I. Axel, W. Kunert, C. Goggelmann Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
18. E. Diderholm, B. Andren, G. Frostfeldt Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease the FRISC II invasive troponin T electrocardiogram substudy Am Heart J 143 2002 760 767
19. R.J. Peters, S.R. Mehta, K.A. Fox Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687
20. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd CREDO Investigators Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
21. B.M. Scirica, C.P. Cannon, C.H. McCabe Thrombolysis In Myocardial Ischemia III Registry Investigators Prognosis in the Thrombolysis In Myocardial Ischemia III registry according to the Braunwald unstable angina pectoris classification Am J Cardiol 90 2002 821 826